Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for SLNO

Stock NameSoleno Therapeutics Inc
TickerSLNO(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS8342032005

Show aggregate SLNO holdings

News associated with SLNO

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of “Buy” by Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average rating of “Buy” from the twelve research firms that are presently covering the firm, Marketbeat reports. Eleven analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year […] - 2025-08-28 02:24:50
Notable Friday Option Activity: CSCO, SLNO, MDB
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cisco Systems Inc (Symbol: CSCO), where a total volume of 148,281 contracts has been traded thus far today, a contract volume which is representative of approxim - 2025-08-15 16:27:16
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $108.70 Consensus Price Target from Brokerages
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has received a consensus recommendation of “Buy” from the eleven analysts that are presently covering the company, Marketbeat.com reports. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target […] - 2025-08-06 02:30:59
Soleno Therapeutics (NASDAQ:SLNO) Raised to “Hold” at Wall Street Zen
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other analysts also recently weighed in on the company. HC Wainwright restated a “buy” rating and set a $100.00 target price on shares of Soleno Therapeutics […] - 2025-07-28 04:00:47
Arizona State Retirement System Has $527,000 Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Arizona State Retirement System boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,380 shares of the company’s stock after purchasing an additional 620 shares during the […] - 2025-07-22 07:43:03
Arizona State Retirement System Has $527,000 Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Arizona State Retirement System boosted its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,380 shares of the company’s stock after buying an additional 620 shares during […] - 2025-07-22 06:56:57
Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $121.00
Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its target price lifted by Robert W. Baird from $105.00 to $121.00 in a research note released on Friday morning,Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts have also weighed in on SLNO. Stifel Nicolaus increased their target price […] - 2025-07-14 03:30:49
Avior Wealth Management LLC Grows Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Avior Wealth Management LLC grew its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 72.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,410 shares of the company’s stock after buying an additional 1,437 shares during […] - 2025-06-24 04:52:53
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $106.78 Average Target Price from Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have earned an average recommendation of “Buy” from the nine research firms that are currently covering the firm, MarketBeat.com reports. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price […] - 2025-06-17 03:08:55
California State Teachers Retirement System Has $988,000 Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
California State Teachers Retirement System boosted its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 23.6% in the fourth quarter, HoldingsChannel reports. The firm owned 21,977 shares of the company’s stock after acquiring an additional 4,201 shares during the period. California State Teachers Retirement System’s holdings in Soleno Therapeutics were worth […] - 2025-06-11 05:04:47
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 24.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,504 shares of the company’s stock […] - 2025-06-10 04:20:47
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Bought by ProShare Advisors LLC
ProShare Advisors LLC lifted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 64.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,206 shares of the company’s stock after buying an additional 2,836 shares during […] - 2025-05-30 05:06:50
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Recommendation of “Buy” from Analysts
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has earned an average recommendation of “Buy” from the nine research firms that are covering the stock, MarketBeat reports. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among […] - 2025-05-20 02:31:41
Deutsche Bank AG Purchases 36,971 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Deutsche Bank AG grew its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 44.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 119,455 shares of the company’s stock after buying an additional 36,971 shares during the period. Deutsche Bank […] - 2025-05-19 05:07:01
BNP Paribas Financial Markets Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
BNP Paribas Financial Markets purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 71,320 shares of the company’s stock, valued at approximately $3,206,000. BNP Paribas Financial Markets owned 0.17% of Soleno Therapeutics […] - 2025-05-16 05:08:56
Reviewing Soleno Therapeutics (NASDAQ:SLNO) & Guided Therapeutics (OTCMKTS:GTHP)
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Profitability This table compares Soleno Therapeutics and Guided […] - 2025-04-29 02:22:53
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Legal & General Group Plc
Legal & General Group Plc grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 23,471 shares of the company’s stock after purchasing an additional 1,983 shares during the quarter. Legal & General Group Plc’s holdings in Soleno Therapeutics were worth […] - 2025-04-28 04:56:52
Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) PT at $104.67
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price […] - 2025-04-28 02:39:09
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $94.57 Consensus PT from Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average recommendation of “Buy” from the nine ratings firms that are presently covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average […] - 2025-04-03 02:35:01
Soleno Therapeutics (NASDAQ:SLNO) Sees Strong Trading Volume Following Analyst Upgrade
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) saw unusually-high trading volume on Monday after HC Wainwright raised their price target on the stock from $70.00 to $100.00. HC Wainwright currently has a buy rating on the stock. Approximately 891,497 shares traded hands during mid-day trading, an increase of 40% from the previous […] - 2025-04-01 02:54:47
Stocks Finish Lower as Tariffs Cloud the Economic Outlook
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.37%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.59%. June E-mini S&P futures (ESM25 ) are down -0.32%, and June E-mini Nasdaq futures... - 2025-03-28 10:31:16
Swiss National Bank Boosts Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Swiss National Bank lifted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 27.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,900 shares of the company’s stock after purchasing an additional 9,900 shares during the quarter. Swiss National […] - 2025-03-28 06:28:50
Stocks Trade Mixed on Strong Economic Data, Lingering Tariff Uncertainty
The S&P 500 Index ($SPX ) (SPY ) today is down -0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. June E-mini S&P futures (ESM25 ) are down -0.07%, and June E-mini Nasdaq futures... - 2025-03-27 19:46:46
Stocks Bounce Back as Investors Shrug Off Auto Tariffs
The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.32%. June E-mini S&P futures (ESM25 ) are up +0.29%, and June E-mini Nasdaq futures... - 2025-03-27 18:09:37
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Rating of “Buy” from Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received an average recommendation of “Buy” from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-06 05:21:27
Soleno Therapeutics (NASDAQ:SLNO) Earns “Buy” Rating from HC Wainwright
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $70.00 target price on the stock. HC Wainwright’s price objective would indicate a potential upside of 57.52% from the company’s previous close. A number of other […] - 2025-03-05 05:04:52
Allspring Global Investments Holdings LLC Decreases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Allspring Global Investments Holdings LLC trimmed its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 128,028 shares of the company’s stock after selling 13,396 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Soleno Therapeutics were worth $5,755,000 […] - 2025-02-20 06:24:48
Soleno Therapeutics (NASDAQ:SLNO) Upgraded at Lifesci Capital
Lifesci Capital upgraded shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) to a strong-buy rating in a research report report published on Tuesday morning,Zacks.com reports. Lifesci Capital also issued estimates for Soleno Therapeutics’ Q4 2024 earnings at ($0.37) EPS, Q1 2025 earnings at ($1.67) EPS, Q2 2025 earnings at ($1.13) EPS, Q3 2025 earnings at […] - 2025-02-07 06:36:55

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc SLNO holdings

DateNumber of SLNO Shares HeldBase Market Value of SLNO SharesLocal Market Value of SLNO SharesChange in SLNO Shares HeldChange in SLNO Base ValueCurrent Price per SLNO Share HeldPrevious Price per SLNO Share Held
2025-09-29 (Monday)16,081USD 1,096,081USD 1,096,081
2025-09-26 (Friday)16,081USD 1,044,622USD 1,044,622
2025-09-25 (Thursday)16,081USD 1,008,600SLNO holding decreased by -28625USD 1,008,6000USD -28,625 USD 62.72 USD 64.5
2025-09-24 (Wednesday)16,081USD 1,037,225USD 1,037,225
2025-09-17 (Wednesday)15,977USD 814,507SLNO holding increased by 20290USD 814,5070USD 20,290 USD 50.98 USD 49.71
2025-09-16 (Tuesday)15,977USD 794,217USD 794,217
2025-09-12 (Friday)15,873USD 851,110USD 851,110
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SLNO by Blackrock for IE00B3VWM098

Show aggregate share trades of SLNO

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-43 69.800* 64.32 Profit of 2,766 on sale
2025-07-31BUY129 86.470* 64.16
2025-06-30SELL-86 83.780* 61.37 Profit of 5,278 on sale
2025-06-25SELL-43 85.790* 60.89 Profit of 2,618 on sale
2025-06-20SELL-86 79.980* 60.44 Profit of 5,198 on sale
2025-05-30BUY2,350 73.350* 58.37
2025-05-23BUY35 76.890* 57.62
2025-05-19SELL-35 75.580* 57.04 Profit of 1,997 on sale
2025-05-15SELL-105 75.070* 56.73 Profit of 5,956 on sale
2025-05-12SELL-35 76.700* 56.24 Profit of 1,968 on sale
2025-05-09SELL-35 76.780* 56.05 Profit of 1,962 on sale
2025-04-30SELL-35 74.860* 54.75 Profit of 1,916 on sale
2025-04-24SELL-70 74.230* 53.97 Profit of 3,778 on sale
2025-04-17SELL-35 69.980* 53.09 Profit of 1,858 on sale
2025-04-15SELL-105 70.250* 52.72 Profit of 5,536 on sale
2025-04-14SELL-105 70.000* 52.53 Profit of 5,516 on sale
2025-04-09SELL-140 63.270* 52.12 Profit of 7,297 on sale
2025-04-07SELL-245 69.640* 51.84 Profit of 12,701 on sale
2025-04-04SELL-350 67.480* 51.66 Profit of 18,080 on sale
2025-03-31BUY35 71.450* 50.94
2025-03-19SELL-70 48.780* 50.58 Profit of 3,540 on sale
2025-03-14SELL-210 49.340* 50.61 Profit of 10,629 on sale
2025-03-13SELL-70 49.030* 50.63 Profit of 3,544 on sale
2025-03-12SELL-1,190 46.700* 50.69 Profit of 60,323 on sale
2025-03-07SELL-70 44.780* 50.98 Profit of 3,568 on sale
2025-03-06SELL-105 44.940* 51.07 Profit of 5,362 on sale
2025-03-03SELL-35 45.800* 51.36 Profit of 1,798 on sale
2025-02-28SELL-210 48.820* 51.40 Profit of 10,794 on sale
2025-02-26SELL-35 45.100* 51.62 Profit of 1,807 on sale
2025-02-25SELL-105 44.860* 51.73 Profit of 5,432 on sale
2025-02-18BUY175 48.070* 52.20
2025-02-13BUY35 51.330* 52.34
2025-02-12BUY35 50.250* 52.38
2025-02-11BUY105 49.400* 52.44
2025-02-06BUY315 50.980* 52.57
2025-01-27BUY35 46.810* 53.27
2024-12-30BUY175 45.300* 54.05
2024-12-06BUY140 49.150* 54.64
2024-12-05BUY35 49.650* 54.81
2024-12-04BUY175 50.670* 54.96
2024-11-29BUY175 52.710* 55.40
2024-11-27BUY140 55.840* 55.36
2024-11-26BUY35 58.340* 55.23
2024-11-25BUY2,090 57.220* 55.13
2024-11-21BUY140 54.630* 55.02
2024-11-20BUY84 54.830* 55.03
2024-11-18BUY336 51.640* 55.45
2024-11-12BUY224 57.310* 55.32
2024-11-08BUY140 57.050* 55.20
2024-11-07BUY420 57.110* 55.05
2024-11-06BUY56 56.860* 54.90
2024-10-31BUY28 55.060* 54.42
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SLNO

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19608,8650745,85881.6%
2025-09-181,241,9035,3011,548,86780.2%
2025-09-17518,87701,080,25548.0%
2025-09-16330,132451,290,84225.6%
2025-09-15280,2000950,97329.5%
2025-09-12407,554501,253,80232.5%
2025-09-11440,18317,4031,092,27540.3%
2025-09-101,588,94288,9844,369,44936.4%
2025-09-09183,9680395,05246.6%
2025-09-08187,8580270,19869.5%
2025-09-05143,982318247,25758.2%
2025-09-04318,9531,806490,39865.0%
2025-09-03206,7040361,80957.1%
2025-09-02327,0819,078458,59671.3%
2025-08-29181,245488299,74160.5%
2025-08-28227,1901,400366,57162.0%
2025-08-27354,2110469,38175.5%
2025-08-26278,8250541,50351.5%
2025-08-25183,662978426,42143.1%
2025-08-22271,6971,335466,63658.2%
2025-08-21411,708618577,05271.3%
2025-08-20376,8470653,20157.7%
2025-08-19239,9000600,56939.9%
2025-08-18356,04717,859784,49045.4%
2025-08-151,511,40711,6093,088,69248.9%
2025-08-14677,905200,6571,137,35959.6%
2025-08-13617,389338,747970,53563.6%
2025-08-12320,068158,746411,31877.8%
2025-08-11489,908198,345807,18560.7%
2025-08-08265,8980354,10775.1%
2025-08-07376,234105548,37168.6%
2025-08-06129,95420387,93833.5%
2025-08-05197,763372317,73662.2%
2025-08-04131,501245245,30753.6%
2025-08-01236,3410441,05453.6%
2025-07-31259,4400641,49440.4%
2025-07-30217,19857642,88233.8%
2025-07-29238,6630589,01640.5%
2025-07-28207,9180536,74538.7%
2025-07-25226,63791446,49750.8%
2025-07-24214,977274395,24754.4%
2025-07-23220,2840305,23972.2%
2025-07-22266,909485472,28656.5%
2025-07-21240,86845385,47062.5%
2025-07-18207,76086389,27053.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.